Your browser doesn't support javascript.
loading
Refining AML Treatment: The Role of Genetics in Response and Resistance Evaluation to New Agents.
Halik, Adriane; Arends, Christopher Maximilian; Bullinger, Lars; Damm, Frederik; Frick, Mareike.
Afiliación
  • Halik A; Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, 13353 Berlin, Germany.
  • Arends CM; BIH Charité Junior Clinician Scientist Program, Berlin Institute of Health at Charité, BIH Biomedical Innovation Academy-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Bullinger L; Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, 13353 Berlin, Germany.
  • Damm F; BIH Charité Junior Clinician Scientist Program, Berlin Institute of Health at Charité, BIH Biomedical Innovation Academy-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Frick M; Medical Department, Division of Hematology, Oncology, and Cancer Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, 13353 Berlin, Germany.
Cancers (Basel) ; 14(7)2022 Mar 26.
Article en En | MEDLINE | ID: mdl-35406464
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza